Alamar Biosciences director reports stock options
Alamar Biosciences director Witney Frank has reported existing stock option holdings for Class B Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Alamar Biosciences director Witney Frank has reported existing stock option holdings for Class B Common Stock. The filing lists three option awards with exercise prices of $0.59, $3.10 and $7.60 per share, covering 49,627, 33,085 and 124,069 underlying shares, expiring between 2031 and 2036.
Footnotes state that one option is fully vested, while others vest in monthly installments over 48 months, with a portion beginning to vest on January 15, 2027 and another measured from January 1, 2025, contingent on continuous service.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Witney Frank
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 206,781 contracts (Direct)
Footnotes (3)
- F1. Twenty-five percent of the shares subject to the option vest on 1/15/2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.
- F2. Fully vested.
- F3. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
Key Figures
Option 1 exercise price: $3.10 per share
Option 1 underlying shares: 33,085 shares
Option 2 exercise price: $0.59 per share
+5 more
8 metrics
Option 1 exercise price
$3.10 per share
Stock Option (Right to Buy) on Class B Common Stock
Option 1 underlying shares
33,085 shares
Underlying Class B Common Stock at $3.10 exercise price
Option 2 exercise price
$0.59 per share
Stock Option (Right to Buy) on Class B Common Stock
Option 2 underlying shares
49,627 shares
Underlying Class B Common Stock at $0.59 exercise price
Option 3 exercise price
$7.60 per share
Stock Option (Right to Buy) on Class B Common Stock
Option 3 underlying shares
124,069 shares
Underlying Class B Common Stock at $7.60 exercise price
Earliest option expiration
April 20, 2031
Expiration date of one stock option grant
Latest option expiration
January 14, 2036
Expiration date of another stock option grant
Key Terms
Stock Option (Right to Buy), Class B Common Stock, vest, fully vested, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for each derivative entry"
Class B Common Stock financial
"underlying_security_title: "Class B Common Stock" associated with each option"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
vest financial
"1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
fully vested financial
"Footnote stating: "Fully vested.""
continuous service financial
"subject to the reporting person's continuous service through each such vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Alamar Biosciences (ALMR) Form 3 for Witney Frank show?
The Form 3 shows director Witney Frank’s existing stock option holdings in Alamar Biosciences. It lists three stock option awards on Class B Common Stock with specified exercise prices, share amounts, expiration dates, and detailed vesting schedules tied to continued service.
What are the exercise prices of Witney Frank’s Alamar Biosciences (ALMR) options?
The filing discloses exercise prices of $0.59, $3.10 and $7.60 per share for three stock option grants. Each option relates to Class B Common Stock and has distinct expiration dates ranging from 2031 through 2036, as reported in the derivative holdings table.
When do Witney Frank’s Alamar Biosciences (ALMR) options expire?
The options expire on April 20, 2031, April 15, 2035 and January 14, 2036. Each expiration date corresponds to a different option with its own exercise price and underlying share count, indicating long-dated equity incentives tied to continued service.
How do Witney Frank’s Alamar Biosciences (ALMR) options vest?
One option is described as fully vested. Another vests 25% on January 15, 2027 with 1/48th monthly thereafter, and a third vests in equal monthly installments over 48 months from January 1, 2025, all requiring continuous service at each vesting date.
Does the Alamar Biosciences (ALMR) Form 3 show recent insider buying or selling?
No recent buying or selling activity is identified in this Form 3. The entries are coded as holdings of stock options, with transaction direction classified as unknown and transaction counts for buys, sells, and exercises all reported as zero in the summary section.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates